Testing an experimental drug in people with healthy or reduced kidney function
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests a new tablet, HRS-1301, to see how it is processed by the body in people with different levels of kidney function. It aims to help doctors understand dosing for patients with kidney impairment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have a body weight of at least 110 pounds (50 kg) for men or 99 pounds (45 kg) for women.
- Your body mass index (BMI) is between 18 and 30.
- You have either normal kidney function or mild, moderate, or severe kidney impairment (confirmed by a recent GFR test).
- You have no history of heart problems like heart failure, irregular heartbeat, or heart attack.
- You have no history of cancer in the past 5 years (except treated skin cancer or cervical precancer).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how a new drug called HRS-1301 changes the way your body processes two common medications: midazolam (a sedative) and atorvastatin (a cholesterol drug). Healthy volunteers help researchers understand drug safety and interactions before testing in patients with illness.
This study tests an experimental drug called HRS-1301 to see if it safely lowers LDL ("bad") cholesterol in people with high cholesterol. It is for adults who either already have artery disease or are at higher risk for it.
This trial tests an investigational drug called HRS-1780 in people with chronic kidney disease. It aims to see if the drug can help slow kidney decline and is safe to use.
This study tests HRS-7535, a new oral tablet that may help protect kidneys in people with chronic kidney disease. GLP-1 medications were originally developed for diabetes but may also benefit kidney function and overall health.
This is an early-stage safety test of a new experimental drug called HRS-5765 in people without serious health conditions. Researchers want to make sure the drug is safe and understand how your body processes it.
This study tests different forms of an experimental medicine called HRS-5346 to see how the body absorbs them. It is for healthy people aged 18 to 45, and the results will help decide which version to use in future studies.
Hear when a new Hyperlipidemias trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.